Northern Antibiotics Oy - Product Pipeline Review - 2015

Northern Antibiotics Oy - Product Pipeline Review - 2015

Jun 2015 Global Markets Direct Antibiotics20 Pages Price :
$ 1500

Northern Antibiotics Oy - Product Pipeline Review - 2015


Global Markets Directs, Northern Antibiotics Oy - Product Pipeline Review - 2015, provides an overview of the Northern Antibiotics Oys pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Northern Antibiotics Oys, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of Northern Antibiotics Oy including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Northern Antibiotics Oys human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Northern Antibiotics Oys pipeline products

Reasons to buy

- Evaluate Northern Antibiotics Oys strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Northern Antibiotics Oy in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Northern Antibiotics Oys R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Northern Antibiotics Oy and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Northern Antibiotics Oy
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Northern Antibiotics Oy and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Northern Antibiotics Oy Snapshot 4
Northern Antibiotics Oy Overview 4
Key Information 4
Key Facts 4
Northern Antibiotics Oy - Research and Development Overview 5
Key Therapeutic Areas 5
Northern Antibiotics Oy - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Northern Antibiotics Oy - Pipeline Products Glance 10
Northern Antibiotics Oy - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Northern Antibiotics Oy - Drug Profiles 11
NAB-7061 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
NAB-739 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
NAB-741 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Northern Antibiotics Oy - Pipeline Analysis 15
Northern Antibiotics Oy - Pipeline Products by Target 15
Northern Antibiotics Oy - Pipeline Products by Molecule Type 16
Northern Antibiotics Oy - Pipeline Products by Mechanism of Action 17
Northern Antibiotics Oy - Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 19
Disclaimer 20

List of Tables
Northern Antibiotics Oy, Key Information 4
Northern Antibiotics Oy, Key Facts 4
Northern Antibiotics Oy - Pipeline by Indication, 2015 7
Northern Antibiotics Oy - Pipeline by Stage of Development, 2015 8
Northern Antibiotics Oy - Monotherapy Products in Pipeline, 2015 9
Northern Antibiotics Oy - Preclinical, 2015 10
Northern Antibiotics Oy - Pipeline by Target, 2015 15
Northern Antibiotics Oy - Pipeline by Molecule Type, 2015 16
Northern Antibiotics Oy - Pipeline Products by Mechanism of Action, 2015 17

List of Figures
Northern Antibiotics Oy - Pipeline by Top 10 Indication, 2015 6
Northern Antibiotics Oy - Pipeline by Top 10 Molecule Type, 2015 16

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report

Select License Type :

$ 1500
$ 3000

Do you wish to check sample of this report?

Have Query?

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top